摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-碘-N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶苯胺 | 155204-23-2

中文名称
4-碘-N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶苯胺
中文别名
——
英文名称
4-iodo-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-pyridin-2-ylbenzylamide
英文别名
4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-iodobenzamido]-ethyl-piperazine;4-(2'-methoxyphenyl)-1-[2'-[N-(2'-pyridinyl)-p-iodobenzamido]ethyl]piperazine;4-iodo-N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)benzamide;p-MPPI hydrochloride;p-MPPI;4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridinyl)-p-iodobenzamido]ethyl-piperazine;4-iodo-N-{2-[4-(methoxyphenyl)-1-piperazinyl]ethyl}-N-2-pyridinylbenzamide;4-iodo-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide
4-碘-N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶苯胺化学式
CAS
155204-23-2
化学式
C25H27IN4O2
mdl
——
分子量
542.419
InChiKey
DHMLNZRDVQLQBB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    657.5±55.0 °C(Predicted)
  • 密度:
    1.460±0.06 g/cm3(Predicted)
  • 溶解度:
    H2O:2.4 mg/mL

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    32
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    48.9
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:aa38ffd0551e5acb81c1efd7daabbcae
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • The Use of Lithium Amides in the Palladium-Mediated Synthesis of [Carbonyl-11C]Amides
    作者:Oleksiy Itsenko、Elisabeth Blom、Bengt Långström、Tor Kihlberg
    DOI:10.1002/ejoc.200700255
    日期:2007.9
    Weakly nucleophilic amines were converted into the corresponding lithium amides and used in either one- or two-pot palladium mediated-reactions with [11C]carbon monoxide and aryl iodides. It was fo ...
    弱亲核胺被转化为相应的氨基化锂,并用于与 [ 11 C] 一氧化碳和芳基碘化物的一锅或两锅钯介导的反应。这是为了...
  • Method for improving respiratory function and inhibiting muscular degeneration
    申请人:The Children's Medical Center Corporation
    公开号:US20030139422A1
    公开(公告)日:2003-07-24
    The present invention provides a method for improving respiratory function and inhibiting muscular degeneration (e.g., dystrophy and atrophy). Alternative embodiments of the invention provide a method of inhibiting motor neuron apoptosis and the subsequent muscular degeneration associated with the denervation of muscular tissue resulting from neuron death.
    本发明提供了一种改善呼吸功能和抑制肌肉退化(例如,肌萎缩和萎缩)的方法。本发明的另一实施例提供了一种抑制运动神经元凋亡和由神经元死亡引起的肌肉组织去神经化所致的肌肉退化的方法。
  • Synthesis And Evaluation of 4-(2'-Methoxyphenyl)-1-[2'-[N-(2''-pyridinyl)- p-iodobenzamido]ethyl]piperazine (p-MPPI): A New Iodinated 5-HT1A Ligand
    作者:Zhi-Ping Zhuang、Mei-Ping Kung、Hank F. Kung
    DOI:10.1021/jm00036a003
    日期:1994.5
  • Screening of 5-HT<sub>1A</sub> Receptor Antagonists using Molecularly Imprinted Polymers
    作者:Naphtali A. O'Connor、David A. Paisner、Donna Huryn、Kenneth J. Shea
    DOI:10.1021/ja067276c
    日期:2007.2.1
    Molecular imprinting produces network polymers with recognition sites for imprint molecules. The high binding affinity and selectivity in conjunction with the polymers' physical robustness positions molecular imprinted polymers (MIPs) as candidates for use as preliminary screens in drug discovery. As such, MIPs can serve as crude mimics of native receptors. In an effort to evaluate the relationship between MIPs and native receptors, imprinted polymers for WAY-100635, an antagonist of the serotonin (5-HT) receptor subtype 5-HT1A were prepared. The resulting MIP P(WAY) was evaluated as an affinity matrix in the screening of serotonin receptor antagonists with known affinities for the native receptor. Rough correlations in affinity between the synthetic P(WAY) and native receptor 5-HT1A were found. These findings provide some support for the analogy between MIPs and native receptors and their possible use as surrogates.
  • US7071194B2
    申请人:——
    公开号:US7071194B2
    公开(公告)日:2006-07-04
查看更多